Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment. Kreft KL, Robertson NP. J Neurol 2022 Aug 1. pii: 10.1007/s00415-022-11300.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kreft KL, Robertson NP. Innovative biomarkers to predict unfavourable outcomes after initiating multiple sclerosis treatment. J Neurol 2022 Aug 1. pii: 10.1007/s00415-022-11300.
PMID: 35913607